Castration-resistant prostate cancer: systemic therapy in 2012
Prostate cancer is the most common non-cutaneous neoplasm in the male population worldwide.It is typically diagnosed in its early stages, and the disease exhibits a relatively indolent course in most patients.Despite the curability of localized disease with prostatectomy and radiation therapy, some patients develop metastatic disease and die.Althou